LU81430A1 - Nouvelles cystamines - Google Patents

Nouvelles cystamines Download PDF

Info

Publication number
LU81430A1
LU81430A1 LU81430A LU81430A LU81430A1 LU 81430 A1 LU81430 A1 LU 81430A1 LU 81430 A LU81430 A LU 81430A LU 81430 A LU81430 A LU 81430A LU 81430 A1 LU81430 A1 LU 81430A1
Authority
LU
Luxembourg
Prior art keywords
formula
compound
acid addition
optionally
hch
Prior art date
Application number
LU81430A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU81430A1 publication Critical patent/LU81430A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C07C323/44—X or Y being nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU81430A 1978-06-27 1979-06-27 Nouvelles cystamines LU81430A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91959778 1978-06-27
US05/919,597 US4157340A (en) 1978-06-27 1978-06-27 N,N'-[Bis(N-cyanoguanyl)]cystamine derivatives

Publications (1)

Publication Number Publication Date
LU81430A1 true LU81430A1 (fr) 1980-01-22

Family

ID=25442355

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81430A LU81430A1 (fr) 1978-06-27 1979-06-27 Nouvelles cystamines

Country Status (23)

Country Link
US (1) US4157340A (ja)
JP (1) JPS5834471B2 (ja)
AU (1) AU521689B2 (ja)
BE (1) BE877317A (ja)
CA (1) CA1118445A (ja)
CH (1) CH641444A5 (ja)
CY (1) CY1276A (ja)
DE (1) DE2925803A1 (ja)
DK (1) DK270279A (ja)
FR (1) FR2429778A1 (ja)
GB (1) GB2023579B (ja)
GR (1) GR73537B (ja)
HK (1) HK20185A (ja)
IE (1) IE48763B1 (ja)
IT (1) IT1120444B (ja)
KE (1) KE3495A (ja)
LU (1) LU81430A1 (ja)
MY (1) MY8500947A (ja)
NL (1) NL7904914A (ja)
SE (1) SE7905609L (ja)
SG (1) SG89084G (ja)
YU (1) YU41643B (ja)
ZA (1) ZA793133B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
JPS5533416A (en) * 1978-08-31 1980-03-08 Sogo Yatsukou Kk Production of hexamethyene bis-dicyandiamide
AR229878A1 (es) * 1981-05-07 1983-12-30 Glaxo Group Ltd Procedimiento para preparar ranitidina
GB2122612B (en) * 1982-06-16 1985-09-25 May & Baker Ltd Cystamine derivatives
JPH0655711B2 (ja) * 1986-09-12 1994-07-27 三井石油化学工業株式会社 シアノグアニジン誘導体の製造方法
IT1215344B (it) * 1987-01-27 1990-02-08 Dessy S R L Ora Recordati Farm Procedimento per la preparazione di composti ad attivita' anti-ulcera.
JPH0696549B2 (ja) * 1987-02-17 1994-11-30 三井石油化学工業株式会社 シアノグアニジン誘導体の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1399283A (en) * 1972-04-20 1975-07-02 Smith Kline French Lab Pharmaceutical compositions
GB1533380A (en) * 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines
GB1578219A (en) * 1975-12-01 1980-11-05 Smith Kline French Lab Isothioureas

Also Published As

Publication number Publication date
IT1120444B (it) 1986-03-26
IT7949534A0 (it) 1979-06-25
BE877317A (fr) 1979-12-27
CA1118445A (en) 1982-02-16
GB2023579A (en) 1980-01-03
DK270279A (da) 1979-12-28
IE48763B1 (en) 1985-05-15
NL7904914A (nl) 1980-01-02
GR73537B (ja) 1984-03-12
YU145879A (en) 1983-01-21
US4157340A (en) 1979-06-05
JPS557282A (en) 1980-01-19
ZA793133B (en) 1980-06-25
MY8500947A (en) 1985-12-31
AU4828179A (en) 1980-01-03
SG89084G (en) 1985-09-13
CH641444A5 (de) 1984-02-29
CY1276A (en) 1985-07-05
HK20185A (en) 1985-03-29
YU41643B (en) 1987-12-31
IE791199L (en) 1979-12-27
KE3495A (en) 1985-02-01
DE2925803A1 (de) 1980-01-03
JPS5834471B2 (ja) 1983-07-27
GB2023579B (en) 1982-09-02
FR2429778A1 (fr) 1980-01-25
AU521689B2 (en) 1982-04-22
SE7905609L (sv) 1979-12-28
FR2429778B1 (ja) 1983-07-18

Similar Documents

Publication Publication Date Title
EP0706512B1 (fr) Derives d'acetamide et leur utilisation comme modificateurs du comportement de prise alimentaire
JP3231042B2 (ja) ２−（２，６−ジ−ハロ−フェニルアミノ）フェニル酢酸の誘導体の硝酸エステルおよびその製造法
EP0109866B1 (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP0117771B1 (fr) Imino-2 pyrrolidines, leur procédé de préparation et leurs applications en thérapeutique
EP0151072A2 (fr) Dérivés de l'acide méthylènediphosphonique, procédé d'obtention et compositions pharmaceutiques antirhumatismales les contenant
LU81430A1 (fr) Nouvelles cystamines
EP0122827B1 (fr) (Carbéthoxy-2 benzalkylamido-4 phénoxy)-1 amino-3 propanols-2, leurs préparations et leurs utilisations en thérapeutique
US4158013A (en) N-Cyano-N'-alkynyl-N"-2-mercaptoethylguanidines
EP0259206B1 (fr) Dérivés de la dihydro-1,4 pyridine leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
EP0042322A1 (fr) Nouveaux dérivés de l'indène, procédés pour leur préparation et des médicaments les contenant
EP0101380A2 (fr) Nicotinamide 1-oxyde N-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant
EP0294258A1 (fr) Dérivés d'hydrazine, procédé d'obtention et compositions pharmaceutiques les contenant
EP0143016A1 (fr) Dérivés de 4-(3-alkynyloxy-2-hydroxy-propyl)-piperazin-1-yl-N-phényl acétamide, leur préparation et leur application en thérapeutique
EP0119107A1 (fr) Nouveaux dérivés du bicyclo(4.2.0)octatriène-1,3,5, leur préparation et leur application en thérapeutique
US3483248A (en) Preparation of 2-(4-biphenylyl) butyric acid
EP1177169A1 (fr) Derives de 6- [(aryl et heteroaryl) oxy]methyl] n aphtalene-2- carboximidamide, leur preparation et leur application en therapeutique
EP0275221B1 (fr) Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant
EP0103503A2 (fr) Amides N-substitués, leurs sels, procédé pour leur préparation et compositions pharmaceutiques en contenant
EP0347305B1 (fr) [(Aryl-4-pipérazinyl-1)-2 éthoxy]-3 p-cymène, les dérivés ortho, méta, para monosubstitués ou disubstitués sur le noyau phényle dudit produit, le procédé de préparation desdits dérivés, et les médicaments contenant lesdits composés comme principe actif
JPS59130856A (ja) １−シアノ−３−（フルオルアルキル）グアニジン
US4735965A (en) 7-oxo-PGI2 -ephedrine salts and their pharmaceutical compositions and methods
EP0067106B1 (fr) Nouveaux éthers de phénol actifs sur le système cardiovasculaire, leur procédé de préparation et leur utilisation dans des médicaments
EP0103500A2 (fr) Dérivés de phénéthyl-1alpha-phényl-pipéridine-3-propanenitrile, leur préparation et leur application en thérapeutique
EP0022407A1 (fr) Cyclophosphathiazènes, procédé pour leur préparation et compositions les contenant
EP0067769A1 (fr) 1,2,3,4,4a,9b-hexahydro-4a-pipérazinylméthyl-4-dibenzofuranones ou 4-dibenzofuranols substitués, procédé de synthèse et application en thérapeutique